Aligos Therapeutics (ALGS) Net Shares Issued and Repurchased (2019 - 2025)
Aligos Therapeutics' Net Shares Issued and Repurchased was $124,000 in Q4 2025, down 10.8% from $139,000 a year earlier.
Analysis
Aligos Therapeutics (ALGS) Net Shares Issued and Repurchased (2019 - 2025) Analysis & Trends
For FY2025, Net Shares Issued and Repurchased at Aligos Therapeutics came in at $304,000, down 30.3% from FY2024.
- Net Shares Issued and Repurchased shows a five-year compound annual growth rate of -23.0% (FY2020 to FY2025).
- In earlier years, Net Shares Issued and Repurchased was $436,000 in FY2024 (-24.0%), $574,000 in FY2023 (+180.0%), $205,000 in FY2022 (-99.7%) and $79.63 million in FY2021.
- Quarterly Net Shares Issued and Repurchased has moved between -$101.56 million (Q2 2025) and $101.74 million (Q1 2025) over five years.
- The best year-over-year quarter for Net Shares Issued and Repurchased over five years was Q2 2021 (growth of 384.1%); the worst was Q3 2022 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 124,000.00 |
| Jun 30, 2025 | -101.56 Mn |
| Mar 31, 2025 | 101.74 Mn |
| Dec 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Jun 30, 2023 | 461,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 74,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 112,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 720,000.00 |
| Sep 30, 2021 | 78.60 Mn |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 96,000.00 |
| Dec 31, 2020 | 578,000.00 |
| Sep 30, 2020 | 135,000.00 |
| Jun 30, 2020 | 44,000.00 |
| Mar 31, 2020 | 368,000.00 |
| Dec 31, 2019 | 317,000.00 |
API Access
Aligos Therapeutics Net Shares Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-shares-issued-and-repurchased", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();